Rinkoo Aggarwal, MD
Physical Medicine & Rehabilitation · Louisville, KYNPI 1619971462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Pfizer at 28.6% of the total. Reporting peaked in 2020 at $492 and has fallen 93.9% since, to $30 in 2025.
Across 60 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$358
- Collegium Pharmaceutical, Inc.$221
- Saluda Medical Americas, Inc.$156
- Arbor Pharmaceuticals, Inc.$124
- Medtronic$116
- Biodelivery Sciences International, Inc.$59
- plus $219 from 9 others
What the payments were for
- Food & beverage$1,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 20 | $358 |
| Collegium Pharmaceutical, Inc. | 13 | $221 |
| Saluda Medical Americas, Inc. | 1 | $156 |
| Arbor Pharmaceuticals, Inc. | 8 | $124 |
| Medtronic | 1 | $116 |
| Biodelivery Sciences International, Inc. | 4 | $59 |
| Scilex Pharmaceuticals Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $30 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Flowonix Medical Incorporated | 1 | $25 |
| Boston Scientific | 1 | $19 |
| Kaleo, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| IBSA Pharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,252 in reported general payments places this provider in the 70th percentile of 104 physical medicine & rehabilitation providers in Kentucky.
See all physical medicine & rehabilitation providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $7,746 |
| Midodrine Hcl | 12 | $480 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $345 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $190 |
| Pantoprazole Sodium | 18 | $172 |
| Levetiracetam | 11 | $168 |
| Hydralazine Hcl | 19 | $127 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $114 |
| Oxycodone Hcl | 14 | $106 |
| Atorvastatin Calcium | 26 | $102 |
| Amlodipine Besylate | 25 | $99 |
| ClopidogrelClopidogrel Bisulfate | 19 | $96 |
| Metoprolol Succinate | 13 | $78 |
| Gabapentin | 13 | $64 |
| Ondansetron Hcl | 13 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $358 | $7,74615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 104 physical medicine & rehabilitation providers in Kentucky.
Other physical medicine & rehabilitation in Louisville
- Darryl KaelinLouisville$19K
- Megan NelsonLouisville$3K
- Louie WilliamsLouisville$2K
- Mariko KubinecLouisville$2K
- Daniel KeanLouisville$2K
- Lewis HargettLouisville$2K
- Sarah WagersLouisville$2K
- Rodney ChouLouisville$1K
- Camilo CastilloLouisville$1K
- Lindsay GravesLouisville$943
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.